88981892
Apr 1, 2019
Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder; and pharmaceutical preparations containing tasimelteon for use in the treatment of circadian rhythm sleep disorders; pharmaceutical preparations containing tasimelteon for use in the treatment of Smith-Magenis Syndrome
Pharmaceuticals